Subscribe
(L-R): Monika Rai, Stephen Murnaghan, Jocelyn Ram, Kip Bodi
8 May 2025NewsAmericasMarisa Woutersen

LSPN: Counsel grapple with AI’s impact on training and critical thinking

Experts at LSPN Boston stress the need for cross-disciplinary teams and careful training as artificial intelligence software becomes mainstream, reports Marisa Woutersen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025   Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.
Americas
LSPN: Trump's policy storm causing chaos and confusion
7 May 2025   In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston.
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025   The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston.


Editor's picks

Latham steps into dispute over $6bn treatment, replacing Kirkland
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025

Editor's picks

Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025

More on this story

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025   Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.
Americas
LSPN: Trump's policy storm causing chaos and confusion
7 May 2025   In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston.
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025   The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston.

More on this story

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025   Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.
Americas
LSPN: Trump's policy storm causing chaos and confusion
7 May 2025   In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston.
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025   The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston.

More features

Weil adds two more litigators from larger rival
Why the PTAB’s new expedited filing dates for AIA petitions is positive
Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Latham steps into dispute over $6bn treatment, replacing Kirkland
Patent pollution: Emissions charter aims to clean up IP
Why Trump’s revenue-raising patent plan is riddled with problems
Harvard’s patent portfolio at risk as Trump turns up the pressure
Weil adds leaders from Latham to head up tech and life sciences